HOLMIUM LASER ENUCLEATION IN THE SURGICAL TREATMENT OF PROSTATE ADENOMA IN THE KYRGYZ REPUBLIC
DOI:
https://doi.org/10.54890/1694-8882-2025-3-130Abstract
This article evaluates the effectiveness and safety of the Holmium Laser Enucleation method for the surgical treatment of prostate adenoma in the Kyrgyz Republic. A prospective study conducted between two thousand twenty and two thousand twenty-four included one thousand two hundred eleven patients, categorized into groups based on prostate volume. The study aimed to confirm the method's consistent efficacy regardless of the gland's size. Holmium Laser Enucleation demonstrated high and comparable effectiveness across all patient groups. Post-operative parameters, including the International Prostate Symptom Score and maximum urinary flow rate, showed no statistically significant differences during the twelve-month follow-up period. The average duration of catheterization was twenty-four hours, and hospitalization lasted three days. Temporary stress urinary incontinence was recorded in only three-point six percent of patients. Holmium Laser Enucleation is a safe and effective method for treating prostate adenoma, applicable to glands of any
size. Its advantages, such as minimal blood loss, short hospitalization, and the absence of Transurethral Resection syndrome risk, establish it as an endoscopic alternative to open adenomectomy and the new "gold standard."
Keywords:
benign prostatic adenoma, endoscopic surgery, treatment, safety, efficacyReferences
1. Всемирная организация здравоохранения. Обзор старения. Режим доступа: https://www.who.int/ru/news-room/fact-sheets/detail/ageing-and-health [дата обращения: 14.09.25].
2. Gilling PJ, Cass CB, Cresswell MD, Malcolm AR, Fraundorfer MR. The use of the holmium laser in the treatment of benign prostatic hyperplasia. J Endourol. 1996;10(5):459–461. https://doi.org/10.1089/end.1996.10.459
3. Gravas S, Bachmann A, Drake M, Gacci M, Gratzke C, et al. Management of Non-Neurogenic Male Lower Urinary Tract Symptoms (LUTS), incl. Benign Prostatic Obstruction (BPO). EAU Guidelines. Eur Assoc Urol. 2016.
4. Gilling PJ, Kennett K, Das AK, Thompson D, Fraundorfer MR. Holmium laser enucleation of the prostate (HoLEP) combined with transurethral tissue morcellation: an update on the early clinical experience. J Endourol. 1998;12(5):457–459. https://doi.org/10.1089/end.1998.12.457
5. Fraundorfer MR, Gilling PJ. Holmium:YAG laser enucleation of the prostate combined with mechanical morcellation: preliminary results. Eur Urol. 1998;33(1):69-72. https://doi.org/10.1159/000019535
6. Gupta N, Sivaramakrishna, Kumar R, Dogra PN, Seth A. Comparison of standard transurethral resection, transurethral vapour resection and holmium laser enucleation of the prostate for managing benign prostatic hyperplasia of >40 g. BJU Int. 2006;97(1):8–9. https://doi.org/10.1111/j.1464-410X.2006.05862.x
7. Tan AH, Gilling PJ, Kennett KM, Frampton C, Westenberg AM, Fraundorfer MR. A randomized trial comparing holmium laser enucleation of the prostate with transurethral resection of the prostate for the treatment of bladder outlet obstruction secondary to benign prostatic hyperplasia in large glands (40 to 200 grams). J Urol. 2003;170(4 Pt 1): 1270–1274. https://doi.org/10.1097/01.ju.0000086948.55973.00
8. Еникеев Д.В., Глыбочко П.В., Аляев Ю.Г. и др. Гольмиевая лазерная энуклеация (HoLEP) при гиперплазии простаты маленьких, больших и гигантских размеров. Практические рекомендации. Опыт более 450 операций. Урология. 2016;4:63–69. [Enikeev DV, Glybochko PV, Alyaev YG, et al. Holmium laser enucleation of the prostate (HoLEP) for small, large, and giant prostate hyperplasia. Practical recommendations. Experience of more than 450 surgeries. Urologiya. 2016;4:63–69. (In Russ.)]
9. Cornu JN, Ahyai S, Bachmann A, de la Rosette J, Gilling P, Gratzke C, et al. A systematic review and meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic obstruction: an update. Eur Urol. 2015;67(6):1066–1096. https://doi.org/10.1016/j.eururo.2014.06.017
10. Vincent MW, Gilling PJ. HoLEP has come of age. World J Urol. 2015;33(4):487–493. https://doi.org/10.1007/s00345-014-1443-x
11. Abi Chebel J, Sarkis J, El Helou E, et al. Minimally invasive simple prostatectomy in the era of laser enucleation for high-volume prostates: a systematic review and meta-analysis. Arab J Urol. 2020;19(2):123–129. https://doi.org/10.1080/ 2090598X.2020.1789809
12. Imankulova A, Zurdinova A, Djumalieva G, et al. Evaluation of hospital-level antibiotic use in Kyrgyzstan between 2016 and 2019 based on the World Health Organization AWaRe classification. Biomedicine. 2022;42(2):307–313. https://doi.org/10.51248/.v42i2.1234
13. Mingazova EN, Imankulova AS, Djumalieva GA, Sulaimanova D. The effect of application of monitoring and training programs on quality of antimicrobial drugs use in high-risk departments. Problems Soc Hyg Public Health Hist Med. 2023;31(1):5–10. https://doi.org/10.32687/0869-866X-2023-31-1-5-10
14. Schmidt J, Krediet J, Beutel H, et al. Comparison of perioperative outcomes of holmium laser enucleation of the prostate for standard (≤149 ml) versus very large (≥150 ml) prostate glands: retrospective analysis of a propensity score matched cohort of 326 patients. Eur Urol Open Sci. 2024;71:15–21. https://doi.org/ 10.1016/j.euros.2024.10.019
15. Juaneda R, Thanigasalam R, Rizk J, Perrot E, Theveniaud PE, Baumert H. Holmium laser enucleation versus laparoscopic simple prostatectomy for large adenomas. Actas Urol Esp. 2016;40(1):43–48. https://doi.org/10.1016/ j.acuro.2015.05.010
16. Jones P, Alzweri L, Rai BP, et al. Holmium laser enucleation versus simple prostatectomy for treating large prostates: results of a systematic review and meta-analysis. Arab J Urol. 2016;14(1):50–58. https://doi.org/10.1016/j.aju.2015.10.001
17. Hartung FO, Egen L, Grüne B, et al. Perioperative outcomes and complication rates in holmium laser enucleation of the prostate patients after prior prostate biopsy—does it really make a difference? A propensity score matched analysis. J Endourol. 2024;38(7):675–681. https://doi.org/10.1089/end.2024.0008

